Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sensory System Agents”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Early research (Phase 1)Study completedNCT04032301
What this trial is testing

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Who this might be right for
Post-Traumatic Stress DisordersMajor Depressive Disorder
University of Minnesota 67
Early research (Phase 1)UnknownNCT04309084
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more
Celularity Incorporated 29
Testing effectiveness (Phase 2)Looking for participantsNCT06463028
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Faeth Therapeutics 40
Large-scale testing (Phase 3)Looking for participantsNCT06752759
What this trial is testing

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

Who this might be right for
Severe DepressionModerate DepressionKetamine+16 more
Theresa Jacob, PhD, MPH 40
Early research (Phase 1)Study completedNCT02577250
What this trial is testing

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantStress Disorders, Post-Traumatic
Minneapolis Veterans Affairs Medical Center 20
Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Maimonides Medical Center 15
Large-scale testing (Phase 3)Study completedNCT05051735
What this trial is testing

PARASTOP - Paracetamol With Strong Opioids

Who this might be right for
Cancer PainCancer
Oslo University Hospital 204
Not applicableStudy completedNCT01366196
What this trial is testing

Pregabalin for the Treatment of Pain After Posterior Spinal Fusions

Who this might be right for
Lumbar Spinal Fusions
Hospital for Special Surgery, New York 86
Testing effectiveness (Phase 2)Study completedNCT06253806
What this trial is testing

Stellate Ganglion Block for COVID-induced Parosmia

Who this might be right for
COVID-19-Induced Parosmia
Washington University School of Medicine 48
Early research (Phase 1)Study completedNCT04178993
What this trial is testing

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

Who this might be right for
Methamphetamine Use Disorder
Craig Rush 8
Post-approval studies (Phase 4)UnknownNCT01710163
What this trial is testing

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

Who this might be right for
Bipolar I Disorder
University of Sao Paulo 50
Large-scale testing (Phase 3)Study completedNCT03458078
What this trial is testing

Analgesic Efficacy of Two Adjuvants During Spinal Anaesthesia.

Who this might be right for
Pain, Postoperative
Centre de Maternité de Monastir 150
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Not applicableStudy completedNCT02129595
What this trial is testing

Resveratrol and First-degree Relatives of Type 2 Diabetic Patients

Who this might be right for
Pre-diabetes
Maastricht University Medical Center 15
Testing effectiveness (Phase 2)WithdrawnNCT05991232
What this trial is testing

Repeated Neurocognitive Measurements in Depressed Patients

Who this might be right for
Depression, Unipolar
Jay Fournier
Large-scale testing (Phase 3)WithdrawnNCT01538459
What this trial is testing

Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block

Who this might be right for
Shoulder PainInjury of Shoulder RegionDisorder of Shoulder+2 more
Lifespan
Post-approval studies (Phase 4)Study completedNCT02445339
What this trial is testing

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Who this might be right for
Alcohol DependenceAlcohol Use Disorder
NYU Langone Health 50
Early research (Phase 1)Study completedNCT02045264
What this trial is testing

Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Who this might be right for
Hereditary Angioedema (HAE)
Shire 12
Early research (Phase 1)Ended earlyNCT04489420
What this trial is testing

Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+11 more
Celularity Incorporated 3
Load More Results